Stamaril Yellow Fever Vaccine Service at Chughtai Lab

Stamaril Inj 1’s (Yellow Fever) at Chughtai Lab: An Essential Immunization Guide

Yellow fever is an acute, potentially life-threatening viral hemorrhagic disease caused by the yellow fever virus, an RNA virus belonging to the family Flaviviridae. Transmitted primarily through the bites of infected Aedes and Haemagogus mosquitoes, this disease remains endemic in tropical regions of Sub-Saharan Africa and Central and South America. While many individuals infected with the virus experience mild or asymptomatic cases, a significant percentage progress to a severe systemic phase. This toxic phase is characterized by high fever, jaundice, dark urine, severe abdominal pain, vomiting, and multi-organ failure, often accompanied by hemorrhagic manifestations such as bleeding from the nose, mouth, eyes, or gastrointestinal tract. The mortality rate for patients entering this severe phase can reach up to 50% without advanced supportive care. Because there is currently no specific antiviral treatment for yellow fever, active immunization remains the single most effective public health measure to prevent infection and control outbreaks.

Stamaril, manufactured by Sanofi Pasteur, is a highly effective, live attenuated vaccine containing the 17D-204 strain of the yellow fever virus. It has been utilized globally for decades, demonstrating an exceptional profile of efficacy and safety in stimulating robust, long-lasting active immunity. A single dose of Stamaril is recognized by the World Health Organization (WHO) as sufficient to confer lifelong protection against yellow fever for the vast majority of individuals, eliminating the need for routine booster doses. Chughtai Lab, Pakistan’s premier diagnostic and healthcare network, offers the Stamaril Yellow Fever Vaccine across its extensive network of vaccination centers. By maintaining a strict cold chain and employing highly trained clinical staff, Chughtai Lab ensures that international travelers, humanitarian workers, and at-risk individuals receive authentic, potent vaccines administered under rigorous clinical supervision.

Clinical Procedure: What to Expect

Patient Preparation

Because Stamaril is a live attenuated vaccine, it contains a weakened but active form of the yellow fever virus. Consequently, pre-vaccination screening is the most critical phase of the immunization process to prevent severe adverse events in contraindicated individuals. Patient preparation at Chughtai Lab involves the following essential steps:

• Medical History Disclosure: Patients must provide a complete medical history, including any history of thymus gland disorders, autoimmune diseases, or immunodeficiencies.
• Allergy Screening: Patients must disclose any known allergies, particularly severe allergic reactions (anaphylaxis) to eggs, chicken proteins, neomycin, polymyxin, or any vaccine component.
• Age Verification: The vaccine is contraindicated in infants under 6 months of age and generally avoided in infants aged 6 to 8 months unless the risk of exposure is extremely high.
• Pregnancy and Lactation Status: Women must inform the clinician if they are pregnant, planning to become pregnant, or breastfeeding, as live vaccines are generally avoided during these periods unless travel to an endemic area is unavoidable.
• Medication Review: Patients must list all current medications, especially immunosuppressive therapies such as chemotherapy, radiation, high-dose systemic corticosteroids, or biological response modifiers.
• No Fasting Required: There are no dietary restrictions or fasting requirements before receiving the Stamaril vaccine. Patients are encouraged to be well-hydrated.

During the Procedure

The administration of the Stamaril vaccine at Chughtai Lab is conducted in a sterile, controlled clinical environment. The vaccine is supplied as a freeze-dried powder (lyophilisate) in a single-dose vial, which the clinician reconstitutes with the provided sterile solvent immediately before injection. The standard dose of 0.5 ml is administered either subcutaneously or intramuscularly, typically into the deltoid muscle of the upper arm. The injection site is thoroughly cleansed with an alcohol swab and allowed to dry completely before administration. The injection itself is rapid and may cause a mild, transient stinging sensation. Following administration, patients are strictly required to remain in the Chughtai Lab waiting area for at least 30 minutes. This observation period is a mandatory safety protocol to monitor for any immediate, severe allergic reactions, such as anaphylaxis, ensuring immediate medical intervention can be provided if necessary.

When is Stamaril Yellow Fever Vaccine Performed?

International Travel to Endemic Regions

Travel to countries where yellow fever is endemic represents the primary indication for the Stamaril vaccine. These regions include tropical areas of Sub-Saharan Africa and Central and South America. Because the yellow fever virus is maintained in complex transmission cycles involving primates and mosquitoes, travelers to these areas are at significant risk of exposure, especially if visiting rural, forested, or jungle environments. The Stamaril vaccine stimulates the production of neutralizing antibodies that provide robust protection against the wild-type virus. Chughtai Lab provides this essential immunization to ensure that travelers from Pakistan are fully protected before entering high-risk zones, thereby preventing the acquisition and subsequent importation of the disease.

Mandatory Entry Requirements (ICVP)

Under the International Health Regulations (IHR 2005), many countries require proof of vaccination against yellow fever as a condition of entry. This requirement is particularly strict for travelers arriving from, or transiting through, countries with risk of yellow fever transmission. Proof of vaccination must be documented on an official International Certificate of Vaccination or Prophylaxis (ICVP), commonly known as the “Yellow Card.” The certificate only becomes valid 10 days after the primary vaccination, which is the time required for the body to develop protective levels of neutralizing antibodies. Chughtai Lab assists travelers by administering the authentic Stamaril vaccine and providing the necessary documentation to facilitate hassle-free international travel and compliance with global health regulations.

Residents of Endemic Areas

For individuals residing in or moving to countries where yellow fever is endemic, routine vaccination is the cornerstone of public health defense. In these regions, the risk of transmission is persistent, and outbreaks can occur rapidly, particularly in urban areas with high densities of Aedes aegypti mosquitoes. Continuous exposure to mosquito vectors makes immunization vital for long-term survival and health. By offering the Stamaril vaccine, Chughtai Lab plays a critical role in preventive medicine, helping individuals establish lifelong immunity before relocating to or visiting family in endemic territories.

Laboratory Personnel Handling Yellow Fever Virus

Laboratory technicians, researchers, and virologists who work directly with the yellow fever virus or clinical specimens containing the virus are at high risk of occupational exposure. Accidental needle-sticks, aerosol generation, or contact with broken skin can lead to laboratory-acquired infections. For these specialized professionals, pre-exposure vaccination with Stamaril is a mandatory safety requirement. Chughtai Lab provides targeted immunization services for healthcare and laboratory professionals, ensuring their safety while they conduct vital research and diagnostic work.

Outbreak Response and Control

During localized outbreaks of yellow fever, rapid mass vaccination campaigns are essential to halt transmission and protect vulnerable populations. While yellow fever is not endemic in Pakistan, the presence of the Aedes mosquito vector (which also transmits dengue and chikungunya) means there is a theoretical risk of local transmission if the virus is imported by an infected traveler. Immunizing individuals who have been exposed or are in close contact with imported cases is a key strategy to prevent the establishment of local transmission cycles. Chughtai Lab stands ready to support public health authorities in outbreak response and preventive immunization strategies.

What Does Stamaril Yellow Fever Vaccine Prevent and Evaluate?

Before administering the Stamaril vaccine, a comprehensive clinical evaluation is performed to assess the patient’s suitability for immunization. This screening process evaluates several physiological and pathological parameters to ensure patient safety. The clinical parameters and contraindications evaluated include:

• Hypersensitivity to egg proteins: Absolute contraindication due to the vaccine virus being grown in embryonated chicken eggs.
• Hypersensitivity to chicken proteins: Evaluated to prevent severe systemic allergic reactions.
• History of thymoma: Absolute contraindication due to the risk of vaccine-associated viscerotropic disease.
• History of thymectomy: Absolute contraindication due to altered T-cell immunity.
• Myasthenia gravis: Associated with thymus dysfunction, making the vaccine contraindicated.
• DiGeorge syndrome: Congenital immunodeficiency affecting T-cell development, contraindicated.
• Active malignant neoplasms: Patients undergoing active cancer treatment cannot receive live vaccines.
• Current chemotherapy treatment: Immunosuppressive state that contraindicates live vaccine administration.
• Current radiotherapy treatment: Induces immunosuppression, requiring postponement of vaccination.
• High-dose systemic corticosteroid therapy: Defined as receiving 20 mg/day or more of prednisone for over two weeks.
• Treatment with biological response modifiers: TNF-alpha inhibitors, rituximab, and other biologics contraindicate live vaccines.
• Symptomatic HIV infection: Contraindicated due to severe cellular immunodeficiency.
• Asymptomatic HIV infection with low CD4 count: Contraindicated if CD4+ T-lymphocyte count is below 200 cells/mm³.
• Age less than 6 months: Absolute contraindication due to high risk of vaccine-associated neurotropic disease.
• Age 6 to 8 months: Relative contraindication; only administered under extreme exposure risk.
• Age 60 years or older: Requires careful risk-benefit analysis due to increased risk of YF-AVD and YF-AND.
• Pregnancy status: Generally avoided unless the risk of yellow fever infection is imminent and unavoidable.
• Breastfeeding status: Avoided due to documented cases of vaccine virus transmission to infants through breast milk.
• History of solid organ transplantation: Patients on lifelong immunosuppressive therapy cannot receive live vaccines.
• History of hematopoietic stem cell transplantation: Requires evaluation of immune reconstitution before vaccination.

Turnaround Time and Report Access at Chughtai Lab

At Chughtai Lab, the administration of the Stamaril Yellow Fever Vaccine is designed to be highly efficient, recognizing the time-sensitive nature of international travel preparations. The clinical procedure, including the pre-vaccination screening and vaccine reconstitution, takes approximately 15 to 20 minutes. Following administration, the mandatory 30-minute observation period must be completed to ensure patient safety. Once the observation period is successfully concluded, Chughtai Lab immediately issues the official vaccination certificate, which is stamped and signed by the authorized clinical authority. This immediate turnaround ensures that travelers receive their valid documentation without delay. Additionally, digital records of the vaccination are securely stored in the Chughtai Lab database, allowing patients to access their immunization history online through the official Chughtai Lab patient portal or mobile application at any time.

Stamaril Administration Parameters Overview

Structure / Parameter Evaluated	Normal / Safe Profile	Possible Abnormal / Contraindicated Findings
Age	9 months to 59 years of age	Under 6 months (absolute contraindication); 60 years or older (increased risk of adverse events)
Immune System Status	Fully immunocompetent; no history of immunodeficiency	Severe immunodeficiency, symptomatic HIV, or CD4 count below 200 cells/mm³
Thymus Gland Function	Normal thymus anatomy and function	History of thymoma, thymectomy, myasthenia gravis, or DiGeorge syndrome
Allergic History	No history of severe allergies to vaccine components	Anaphylaxis to eggs, chicken proteins, neomycin, polymyxin, or prior vaccine doses
Pregnancy & Lactation	Non-pregnant and non-lactating status	Active pregnancy or breastfeeding (requires postponement or strict risk-benefit analysis)
Immunosuppressive Therapy	No current use of immunosuppressive drugs	Active chemotherapy, radiotherapy, biologics, or high-dose systemic corticosteroids
Acute Health Status	Afebrile; no active moderate or severe illness	Moderate to severe acute febrile illness (requires postponement of vaccination)
Travel Timeline	Vaccination administered 10 or more days before travel	Vaccination administered less than 10 days before travel (certificate not yet valid)

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Stamaril Yellow Fever Vaccine?

• Experienced healthcare professionals: Our clinical staff are highly trained in the safe reconstitution and administration of live vaccines.
• Patient-focused care: We prioritize patient safety with comprehensive pre-vaccination screening and dedicated post-vaccination observation.
• Quality diagnostic services: Chughtai Lab is a trusted name in healthcare, ensuring the highest standards of clinical excellence.
• Professional reporting: Immediate issuance of official, internationally recognized vaccination certificates (Yellow Cards).
• Modern diagnostic approach: We utilize advanced electronic medical records to securely store and manage your immunization history.
• Comfortable environment: Our vaccination centers are designed to provide a clean, safe, and comfortable experience for all patients.
• Convenient location: With an extensive network of centers across Pakistan, finding a Chughtai Lab location near you is simple.
• Commitment to accurate diagnosis: We ensure that every vaccine administered is authentic, potent, and stored under strict cold chain management.